Communication Awards entries still open!
Entering the singles categories is simple, quick and free, but hurry – the deadline is 16 September 2022
Read More
Author: John Pinching
Valneva and VBI announce partnership for hepatitis B vaccine
Collaboration involves the marketing and distribution of PreHevbri across Europe
Read More
Neuroplast receives medicinal product designation for Neuro-Cells
Designation paves way for wider applications for several neurodegenerative diseases
Read More
UCB reveals new Bimzelx ‘complete skin clearance’ data
Positive data represents a boost for patients with moderate to severe plaque psoriasis
Read More
Brainomix and Bridge Biotherapeutics enter artificial intelligence partnership
Link up will utilise Brainomix’s AI software for the assessment of idiopathic pulmonary fibrosis
Read More- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
